title: Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA.
authors.forename: J A
authors.initials: JA
authors.lastname: Hansen
authors.forename: C
authors.initials: C
authors.lastname: Anasetti
authors.forename: P G
authors.initials: PG
authors.lastname: Beatty
authors.forename: P J
authors.initials: PJ
authors.lastname: Martin
authors.forename: J E
authors.initials: JE
authors.lastname: Sanders
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: E D
authors.initials: ED
authors.lastname: Thomas
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000494:pharmacology; D006086:Graft vs Host Disease / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D006680:HLA Antigens; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology / Q000601:surgery*; D008727:Methotrexate / Q000494:pharmacology; D011379:Prognosis
chemical_list: D003524:Cyclosporins; D006680:HLA Antigens; D008727:Methotrexate